APG Asset Management US’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-4,209
Closed -$416K – 182
2025
Q3
$416K Hold
4,209
– – ﹤0.01% 168
2025
Q2
$396K Hold
4,209
– – ﹤0.01% 168
2025
Q1
$473K Hold
4,209
– – ﹤0.01% 164
2024
Q4
$445K Sell
4,209
-649
-13% -$69.6K ﹤0.01% 173
2024
Q3
$521K Sell
4,858
-171,773
-97% -$18.7M ﹤0.01% 134
2024
Q2
$18.7M Buy
176,631
+2,436
+1% +$287K 0.11% 100
2024
Q1
$22.6M Buy
174,195
+54,806
+46% +$6.85M 0.13% 90
2023
Q4
$14.5M Buy
+119,389
New +$13.3M 0.09% 92

Other funds holding ZBH

APG Asset Management US's ZBH Position: Q4 2025 in Review

APG Asset Management US sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 4,209 shares — an estimated $416K sold.

APG Asset Management US first reported a position in ZBH in Q4 2023 and held it in 8 quarters. The position peaked at $22.6M in Q1 2024. 949 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • APG Asset Management US reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 4,209 Zimmer Biomet shares in Q4 2025, an estimated $416K.
  • APG Asset Management US first reported a position in Zimmer Biomet in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's Zimmer Biomet position peaked at $22.6M in Q1 2024.
  • 949 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.